Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
110 hedge funds and large institutions have $661M invested in Intersect ENT, Inc in 2020 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 34 increasing their positions, 41 reducing their positions, and 22 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
56% more call options, than puts
Call options by funds: $5.45M | Put options by funds: $3.5M
44% more capital invested
Capital invested by funds: $460M → $661M (+$200M)
9% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 22
2% less funds holding
Funds holding: 112 → 110 (-2)
17% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 41
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$19.8M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$10.6M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$9.26M |
| 4 |
BlackRock
New York
|
+$4.49M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$3.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$25.1M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$8.11M |
| 3 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$5.65M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$3.77M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.09M |
XENT Hedge Fund Activity: Q4 2020 in Review
110 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q4 2020, worth a combined $661M — up 44% from $460M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of XENT and 20 opened new positions — a net loss of 2 holders — while 41 trimmed existing stakes and 34 added.
The largest buyer was Artisan Partners, adding an estimated $19.8M. The largest seller was Deerfield Management, cutting an estimated $25.1M.
- 110 institutional investors held Intersect ENT, Inc (XENT) as of Q4 2020, down from 112 in Q3 2020.
- Funds reported $661M of Intersect ENT, Inc stock for Q4 2020, up 44% quarter-over-quarter.
- 20 funds opened new Intersect ENT, Inc positions in Q4 2020 and 22 closed out, a net change of -2 holders.
- The largest Intersect ENT, Inc buyer in Q4 2020 was Artisan Partners, an estimated $19.8M added.
- The largest Intersect ENT, Inc seller in Q4 2020 was Deerfield Management, an estimated $25.1M sold.
Based on aggregated 13F filings for Q4 2020.